glp-1 tracking software health platform TrimRX Visual Progress Tracking for GLP-1
Description
The absence of regional guidelines underscores an urgent need for context-specific recommendations
2016;310:R906R916
In this patient, the effect of tirzepatide on GI motility likely acted synergistically with her other risk factors, tipping a compensated state of chronic constipation and adhesive disease into a clinically significant, refractory small bowel obstruction
Not as a rigid script to follow, but as a value-based compass to steer the journey
[DOI] [PubMed] [Google Scholar] 134.McIntyre RS, Mansur RB, Rosenblat JD, et al
